Passionate People Powering Premier Innovation
Ready to Begin Your iCAD Journey?
Through passionate ingenuity, iCAD delivers transformative innovations to precisely and effectively detect and treat cancer earlier, empowering clinicians to provide quality, cost-effective patient care.
To achieve our mission, iCAD seeks imaginative, dedicated, and humble professionals.
Explore how you can join our team.
Advanced detection. Precision therapy. Superior patient results.
At iCAD, we are passionately focused on accurate cancer detection and targeted cancer care expertly tailored to meet patients’ personalized needs. We design cancer detection and therapy solutions to empower physicians with full confidence to precisely and effectively detect and treat cancer while enabling their patients to live healthy and high-quality lives.
Our commitment is driven by the valuable benefits offered to physicians, facilities and their patients.
Employee Benefits
We offer competitive compensation and benefits. iCAD is an equal opportunity employer.
Health, Dental, Vision and Life insurance
401k Retirement
Flexible Paid Time Off (PTO)
Life at iCAD
Innovation is at the core of our technologies and our culture. Our relentless focus on improving and saving lives begins with our employees’ passion. Together, we deliver inventive, cutting-edge solutions that are revolutionizing cancer care worldwide.
Employee Outings
Employee Events
Holiday Parties
Our Locations
Cancer Detection
iCAD, Inc.
98 Spit Brook Road
Suite 100 Nashua, NH 03062 USA
+1 603 882 5200 phone
www.icadmed.com
Cancer Therapy
Xoft, a subsidiary of iCAD, Inc.
101 Nicholson Lane
San Jose, CA 95134 USA
+1 408 493 1500 phone
www.xoftinc.com
Resources
Precise and Powerful Healthcare Solutions
© 2020, iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.